Can PCV20 (Pneumococcal Conjugate Vaccine 20) be administered to an adult patient at 6 weeks, 10 weeks, and 14 weeks after receiving PCV13 (Pneumococcal Conjugate Vaccine 13)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PCV20 Cannot Be Given at 6,10, and 14 Weeks in Adults

PCV20 is not administered in a multi-dose series at 6-week, 10-week, and 14-week intervals for adults. This dosing schedule does not align with any current Advisory Committee on Immunization Practices (ACIP) recommendations for pneumococcal vaccination in adults aged ≥19 years.

Standard Adult PCV20 Dosing

Adults receive PCV20 as a single dose, not as a multi-dose series. 1 The vaccine is administered once to complete the pneumococcal vaccination series, with timing dependent on prior vaccination history rather than a fixed multi-dose schedule. 1

Recommended Intervals Based on Prior Vaccination

  • For adults who previously received PCV13 only: Administer a single dose of PCV20 at an interval of ≥1 year after the PCV13 dose. 1

  • For adults who previously received PPSV23 only: Administer a single dose of PCV20 at an interval of ≥1 year after the last PPSV23 dose. 1

  • For adults who previously received both PCV13 and PPSV23: Administer a single dose of PCV20 at an interval of ≥5 years after the last pneumococcal vaccine dose. 1

  • For pneumococcal vaccine-naïve adults aged ≥65 years: Administer a single dose of PCV20 without any prior doses required. 1

The Only Multi-Dose PCV20 Schedule: HSCT Recipients

The single exception to the one-dose rule applies specifically to hematopoietic stem cell transplant (HSCT) recipients, who require a 4-dose series. 1

  • Dose 1-3: Administer 3 doses of PCV20, each 4 weeks apart, starting 3-6 months after HSCT. 1

  • Dose 4: Administer the fourth PCV20 dose ≥6 months after the third dose OR ≥12 months after HSCT, whichever is later. 1

This specialized schedule applies exclusively to HSCT recipients and is not used for any other adult population. 1

Why the 6-10-14 Week Schedule Does Not Apply

The intervals of 6 weeks, 10 weeks, and 14 weeks between doses suggest confusion with pediatric vaccination schedules, which use different pneumococcal vaccines (PCV13 or PCV15) in infants. 2 Adult pneumococcal vaccination follows entirely different principles:

  • Minimum intervals are measured in months or years, not weeks (except for the HSCT 4-week interval between the first three doses). 1

  • Most adults require only one lifetime dose of PCV20 to complete their pneumococcal vaccination series. 1

  • Once PCV20 is administered, no additional pneumococcal vaccines are needed in the vast majority of cases. 1

Critical Timing Requirements

For immunocompromised adults (including those with chronic renal failure, HIV infection, malignancies, immunosuppressive therapy, asplenia, or transplant recipients), the minimum interval between PCV13 and PPSV23 can be shortened to ≥8 weeks. 1 However, this shortened interval applies only to the PCV13-to-PPSV23 sequence, not to PCV20 administration, which still requires ≥1 year after prior PCV13. 1

Common Pitfalls to Avoid

  • Do not confuse adult and pediatric pneumococcal vaccination schedules. Adults do not receive multiple doses at short intervals like infants do. 2

  • Do not administer PCV20 before the minimum required interval has elapsed since the last pneumococcal vaccine dose, as this violates ACIP recommendations and may result in suboptimal immune response. 1

  • Do not add PPSV23 after PCV20 administration. Once PCV20 is given, the pneumococcal vaccination series is complete. 1

Related Questions

Can a patient shift from Pneumococcal Conjugate Vaccine 13 (PCV 13) to Pneumococcal Conjugate Vaccine 20 (PCV 20)?
Does a 72-year-old patient with diabetes qualify for Prevnar 20 (Pneumococcal conjugate vaccine) in Ontario if they received Pneumovax 23 (Pneumococcal polysaccharide vaccine) 5 years ago?
Should a 71-year-old female who received Prevnar13 (Pneumococcal conjugate vaccine) 6 years ago and Pneumovax23 (Pneumococcal polysaccharide vaccine) 13 years ago get Prevnar20 (Pneumococcal conjugate vaccine) now?
Is it recommended for a patient to receive Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) before starting Kisqali (Ribociclib)?
Do I need Prevnar 20 (Pneumococcal conjugate vaccine) if I've already received Prevnar 13 (Pneumococcal conjugate vaccine) and Pneumovax 23 (Pneumococcal polysaccharide vaccine)?
What is the recommended series of pneumococcal conjugate vaccine (PCV) immunization for an adult patient who has previously received PCV13 (Pneumococcal Conjugate Vaccine 13-valent)?
What is the best diet for a patient with Polycystic Ovary Syndrome (PCOS) and exocrine pancreatic insufficiency (EPI)?
How to diagnose an air leak in an Implantable Cardioverter-Defibrillator (ICD) in a patient with a history of cardiac surgery or respiratory issues?
What is the maximum dose of divalproex (valproic acid) in 24 hours for an elderly male patient with severely impaired renal function (GFR of 10)?
Why does tachycardia occur in a patient with a malignant infarct?
What is the recommended treatment approach for patients with intermediate or advanced hepatocellular carcinoma (HCC) using Transarterial Chemoembolization (TACE) plus Lenvatinib (levatinib)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.